

          -  Patients with any history of bradyarrhythmia or atrioventricular blocks

          -  Patients who are participating in other drug clinical trials;

          -  Pregnant or lactating women;

          -  ALT / AST> 5 ULN, neutrophils <0.5, platelets less than 50;

          -  Definite diagnosis of rheumatic immune-related diseases;

          -  Long-term oral anti-rejection or immunomodulatory drugs;

          -  Patients with active pulmonary tuberculosis, with definite bacterial and fungal
             infections.
      